BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34678704)

  • 1. Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosis.
    Chow HH; Talbot J; Marstrand L; Lundell H; Roman Siebner H; Bach Søndergaard H; Sellebjerg F
    Mult Scler Relat Disord; 2021 Nov; 56():103296. PubMed ID: 34678704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis.
    Spain RI; Hildebrand A; Waslo CS; Rooney WD; Emmons J; Schwartz DL; Freedman MS; Paz Soldan MM; Repovic P; Solomon AJ; Rinker J; Wallin M; Haselkorn JK; Stuve O; Gross RH; Turner AP
    Front Neurol; 2023; 14():1188124. PubMed ID: 37360346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stressful life events and the risk of primary progressive multiple sclerosis: A population-based case-control study.
    Alsharie AM; Rafiee F; Rezaeimanesh N; Moghadasi AN; Sahraian MA; Eskandarieh S
    Mult Scler Relat Disord; 2021 Jun; 51():102937. PubMed ID: 33857898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.
    Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van der Walt A; Butzkueven H; Kalincik T;
    JAMA Neurol; 2018 Nov; 75(11):1407-1415. PubMed ID: 30083762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative clinical and neuroimaging features of motor-predominant hereditary diffuse leukoencephalopathy with axonal spheroids and primary progressive multiple sclerosis: A preliminary cross-sectional study.
    Saitoh BY; Yamasaki R; Hiwatashi A; Matsushita T; Hayashi S; Mitsunaga Y; Maeda Y; Isobe N; Yoshida K; Ikeda SI; Kira JI
    Mult Scler Relat Disord; 2019 Jun; 31():22-31. PubMed ID: 30901701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking does not influence disability accumulation in primary progressive multiple sclerosis.
    Javizian O; Metz LM; Deighton S; Koch MW
    Eur J Neurol; 2017 Apr; 24(4):624-630. PubMed ID: 28239937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary risk factors of primary progressive multiple sclerosis: A population-based case-control study.
    Rezaeimanesh N; Moghadasi AN; Sahraian MA; Eskandarieh S
    Mult Scler Relat Disord; 2021 Nov; 56():103233. PubMed ID: 34488182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis.
    Rodrigues DN; Paes RA; Vasconcelos CC; Landeira-Fernandez J; Alvarenga MP
    Arq Neuropsiquiatr; 2011 Aug; 69(4):590-5. PubMed ID: 21877025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
    Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
    Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis.
    Pérez-Miralles FC; Prefasi D; García-Merino A; Ara JR; Izquierdo G; Meca-Lallana V; Gascón-Giménez F; Martínez-Ginés ML; Ramió-Torrentà L; Costa-Frossard L; Fernández Ó; Moreno-García S; Maurino J; Carreres-Polo J; Casanova B
    Brain Behav; 2021 Apr; 11(4):e02044. PubMed ID: 33486890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in the gene
    Zhou Y; Graves JS; Simpson S; Charlesworth JC; Mei IV; Waubant E; Barcellos LF; Belman A; Krupp L; Lucas R; Ponsonby AL; Taylor BV;
    J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):864-868. PubMed ID: 28739605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis for relapse rate in multiple sclerosis: Association with LRP2 genetic variation.
    Hilven K; Vandebergh M; Smets I; Mallants K; Goris A; Dubois B
    Mult Scler; 2018 Nov; 24(13):1773-1775. PubMed ID: 29303040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
    Rovaris M; Judica E; Sastre-Garriga J; Rovira A; Sormani MP; Benedetti B; Korteweg T; De Stefano N; Khaleeli Z; Montalban X; Barkhof F; Miller DH; Polman C; Thompson AJ; Filippi M
    Mult Scler; 2008 May; 14(4):455-64. PubMed ID: 18208869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.
    Jia X; Madireddy L; Caillier S; Santaniello A; Esposito F; Comi G; Stuve O; Zhou Y; Taylor B; Kilpatrick T; Martinelli-Boneschi F; Cree BAC; Oksenberg JR; Hauser SL; Baranzini SE
    Ann Neurol; 2018 Jul; 84(1):51-63. PubMed ID: 29908077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis.
    Petruzzo M; Reia A; Maniscalco GT; Luiso F; Lanzillo R; Russo CV; Carotenuto A; Allegorico L; Palladino R; Brescia Morra V; Moccia M
    Eur J Neurol; 2021 Mar; 28(3):893-900. PubMed ID: 33091222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.
    Martinelli-Boneschi F; Esposito F; Scalabrini D; Fenoglio C; Rodegher ME; Brambilla P; Colombo B; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; De Riz M; Serpente M; Cantoni C; Scarpini E; Martinelli V; Galimberti D; Comi G
    Eur J Neurol; 2010 May; 17(5):740-5. PubMed ID: 20067515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study.
    Boles GS; Hillert J; Ramanujam R; Westerlind H; Olsson T; Kockum I; Manouchehrinia A
    Mult Scler; 2023 Sep; 29(10):1209-1215. PubMed ID: 37435869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.